Bristol-Myers Squibb Company PFD CONV 2
BMYMP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $114,647 | $106,160 | $153,254 | $138,479 |
| - Cash | $10,346 | $11,464 | $9,123 | $13,979 |
| + Debt | $51,200 | $41,464 | $40,717 | $45,596 |
| Enterprise Value | $155,501 | $136,160 | $184,848 | $170,096 |
| Revenue | $48,300 | $45,006 | $46,159 | $46,385 |
| % Growth | 7.3% | -2.5% | -0.5% | – |
| Gross Profit | $27,432 | $25,357 | $26,490 | $26,761 |
| % Margin | 56.8% | 56.3% | 57.4% | 57.7% |
| EBITDA | $3,168 | $19,366 | $19,221 | $20,118 |
| % Margin | 6.6% | 43% | 41.6% | 43.4% |
| Net Income | -$8,948 | $8,025 | $6,327 | $6,994 |
| % Margin | -18.5% | 17.8% | 13.7% | 15.1% |
| EPS Diluted | -4.41 | 3.86 | 2.95 | 3.12 |
| % Growth | -214.2% | 30.8% | -5.4% | – |
| Operating Cash Flow | $15,190 | $13,860 | $13,066 | $16,207 |
| Capital Expenditures | -$1,248 | -$1,209 | -$1,118 | -$973 |
| Free Cash Flow | $13,942 | $12,651 | $11,948 | $15,234 |